— Know what they know.
Not Investment Advice
Also trades as: 4502.T (JPX) · $vol 168M · TKPHF (OTC) · $vol 0M

TAK NYSE

Takeda Pharmaceutical Company Limited
1W: +4.2% 1M: +10.7% 3M: +16.6% YTD: +30.8% 1Y: +45.3% 3Y: +52.9% 5Y: +73.7%
$20.27
-0.16 (-0.78%)
After Hours: $20.30 (+0.04, +0.17%)
Weekly Expected Move ±3.0%
$19 $20 $20 $21 $21
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 73 · $65.0B mcap · 3.16B float · 0.094% daily turnover · Short 29% of daily vol
Credit Risk of going bust: lower than 78% of companies Debt: 32.5% of company value Bonds: $208.5M held by 194 funds, 85 bp over Treasuries → details ▾
If the stock fell to about $0.49 (down 98%), Takeda Pharmaceutical Company Limited would be worth roughly what it owes.
Total debt $31.37B against a stock market value of $65.02B.
Distance to default 9.16 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.34B (short-term plus half of long-term), stock volatility 21.6%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

ESG Scores — TAK

Company vs Sector Average

Historical ESG Trend

View All ESG Filings (9)
Date Form Environmental Social Governance ESG Score Filing
2026-06-30 6-K 99.2 84.0 64.4 82.5 SEC ↗
2026-03-31 20-F 59.4 64.5 67.7 63.9 SEC ↗
2025-12-31 6-K 99.2 94.9 64.4 86.2 SEC ↗
2024-03-31 20-F 58.5 65.0 67.7 63.7 SEC ↗
2023-12-31 6-K 72.3 73.4 72.4 72.7 SEC ↗
2023-06-30 6-K 72.9 73.8 73.7 73.5 SEC ↗
2023-03-31 20-F 59.2 68.1 69.1 65.5 SEC ↗
2022-06-30 6-K 70.8 72.7 67.4 70.3 SEC ↗
2019-03-31 20-F 57.6 65.9 67.4 63.6 SEC ↗

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms